BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1255 related articles for article (PubMed ID: 18592932)

  • 21. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP).
    Pengo V; Palareti G; Cucchini U; Molinatti M; Del Bono R; Baudo F; Ghirarduzzi A; Pegoraro C; Iliceto S;
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):241-8. PubMed ID: 17636186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of mechanical heart valve thrombosis through a clinical audit.
    Bharat V; Das NK; Mohanty B; Jha AC; Chawla SC; Dash B; Mohanty R
    J Heart Valve Dis; 2003 May; 12(3):362-9. PubMed ID: 12803337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bridging of oral anticoagulation with low-molecular-weight heparin: experience in 373 patients with renal insufficiency undergoing invasive procedures.
    Hammerstingl C; Omran H;
    Thromb Haemost; 2009 Jun; 101(6):1085-90. PubMed ID: 19492151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perioperative bridging of chronic oral anticoagulation in patients undergoing pacemaker implantation--a study in 200 patients.
    Hammerstingl C; Omran H
    Europace; 2011 Sep; 13(9):1304-10. PubMed ID: 21508005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Our inability to predict thromboembolic events after prosthetic valve surgery.
    Will MB; Bernacca GM; Bell EF; Tolland MM; Lowe GD; Rumley A; Murray HM; Ford I; Wheatley DJ
    J Heart Valve Dis; 2006 Jul; 15(4):570-80; discussion 580. PubMed ID: 16901057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the "LOWERING-IT" Trial.
    Torella M; Torella D; Chiodini P; Franciulli M; Romano G; De Santo L; De Feo M; Amarelli C; Sasso FC; Salvatore T; Ellison GM; Indolfi C; Cotrufo M; Nappi G
    Am Heart J; 2010 Jul; 160(1):171-8. PubMed ID: 20598989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients.
    Daniels PR; McBane RD; Litin SC; Ward SA; Hodge DO; Dowling NF; Heit JA
    Thromb Res; 2009 Jul; 124(3):300-5. PubMed ID: 19232682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is early antithrombotic therapy necessary after tissue mitral valve replacement?
    Colli A; D'Amico R; Mestres CA; Pomar JL; Cámara ML; Ruyra X; Mulet J
    J Heart Valve Dis; 2010 Jul; 19(4):405-11. PubMed ID: 20845885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effectiveness and safety of low-molecular weight heparin versus unfractionated heparin anticoagulation after heart valve surgery.
    Bucci C; Geerts WH; Sinclair A; Fremes SE
    Am J Cardiol; 2011 Feb; 107(4):591-4. PubMed ID: 21184996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
    Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A
    J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose oral anticoagulation in patients with mechanical heart valve prostheses: final report from the early self-management anticoagulation trial II.
    Koertke H; Zittermann A; Tenderich G; Wagner O; El-Arousy M; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Koerfer R
    Eur Heart J; 2007 Oct; 28(20):2479-84. PubMed ID: 17890730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement.
    Koertke H; Minami K; Boethig D; Breymann T; Seifert D; Wagner O; Atmacha N; Krian A; Ennker J; Taborski U; Klövekorn WP; Moosdorf R; Saggau W; Koerfer R
    Circulation; 2003 Sep; 108 Suppl 1():II75-8. PubMed ID: 12970212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anticoagulation in chinese patients with carbomedics mechanical prosthetic heart valves].
    Zhuang W; Zhou XM; Hu JG; Li JM; Yu JF; Jiang L; Hu DX
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):460-2. PubMed ID: 16134606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enoxaparin as bridging anticoagulant treatment in cardiac surgery.
    Rivas-Gándara N; Ferreira-González I; Tornos P; Torrents A; Permanyer-Miralda G; Nicolau I; Arellano-Rodrigo E; Vallejo N; Igual A; Soler-Soler J
    Heart; 2008 Feb; 94(2):205-10. PubMed ID: 17483131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregnancy after mechanical mitral valve replacement.
    Vural KM; Ozatik MA; Uncu H; Emir M; Yurdagök O; Sener E; Tasdemir O
    J Heart Valve Dis; 2003 May; 12(3):370-6. PubMed ID: 12803338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of anticoagulation in patients with prosthetic heart valves undergoing oral and maxillofacial operations.
    Webster K; Wilde J
    Br J Oral Maxillofac Surg; 2000 Apr; 38(2):124-6. PubMed ID: 10864707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry).
    Spyropoulos AC; Turpie AG; Dunn AS; Kaatz S; Douketis J; Jacobson A; Petersen H;
    Am J Cardiol; 2008 Oct; 102(7):883-9. PubMed ID: 18805116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of patients with prosthetic heart valves during non-cardiac surgery.
    Prendergast BD
    Przegl Lek; 2004; 61(6):556-9. PubMed ID: 15724633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.
    Brueck M; Kramer W; Vogt P; Steinert N; Roth P; Görlach G; Schönburg M; Heidt MC
    Eur J Cardiothorac Surg; 2007 Jul; 32(1):108-12. PubMed ID: 17449264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 63.